May 1 (UPI) --Pharmaceutical giant Johnson & Johnson on Wednesday said it is taking steps to resolve a multibillion dollar, cancer-related lawsuit with thousands of individuals over claims that ...
Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news ...
Benzinga - by Vandana Singh, Benzinga Editor. Wednesday, Johnson & Johnson (NYSE:JNJ) announced its intention to proceed with a $6.475 billion settlement to resolve numerous lawsuits related to ...
Johnson & Johnson is proposing a $6.5 billion settlement to resolve thousands of lawsuits claiming its talc products caused ovarian cancer. J&J aims to settle the legal claims through a third ...
Selon un rapport de Reuters publié mardi, la société de soins de santé Johnson & Johnson (NYSE:JNJ) a été condamnée à verser 260 millions de dollars à une femme de l'Oregon. Celle-ci affirmait que son ...
On Sunday, Johnson & Johnson (NYSE:JNJ) ) released updated results from an open-label, multicenter, multi-cohort Phase 1 study of TAR-210 in patients with non–muscle-invasive bladder cancer (NMIBC) ...
Le géant pharmaceutique américain Johnson & Johnson (J&J) a confirmé mardi ses prévisions pour l'exercice… Le laboratoire américain a annoncé son intention d’acquérir la start-up ...
Johnson & Johnson’s MedTech division said Tuesday it plans to submit an application to the U.S. Food and Drug Administration next year to start clinical trials of its general surgery robot. Ottava, ...
03/06 Rapport Therapeutics, soutenu par J&J, vise une valorisation d'environ 637 millions de dollars pour son introduction en bourse aux États-Unis RE 03/06 Rapport Therapeutics, soutenue par J&J ...